Uber will soon send “customized healthy food, groceries & OTC orders directly to patient homes nationwide.”
Category: Enterprise Tech
Lawsuits Allege This Startup Ripped Off Millions From Vendors. Andreessen Horowitz Backed The Former CEO’s New Company Anyway
The venture firm made a repeat investment in Munjal Shah, but his previous company Health IQ is facing allegations of millions in unpaid invoices and one lawsuit is alleging fraud.
Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate
Alzheimer’s disease drug Leqembi will be covered by Medicare once the Food and Drug Administration grants traditional approval, which could come as soon as early July.
UnitedHealth’s Optum Bids $3 Billion For Company In Hot Home Health Space
UnitedHealth Group’s Optum health services business Monday made an unsolicited cash offer of more than $3 billion to the board of home health provider Amedisys.
Alignment Healthcare Loss Narrows As Medicare Advantage Enrollment Grows
Alignment Healthcare reported a $37 million loss in the first quarter that was a bit narrower than last year as its Medicare Advantage enrollment exceeded 109,000.
Centene Makeover Continues As Health Insurer Divests Artificial Intelligence Platform
Centene will divest Apixio, an artificial intelligence platform as the health insurer focuses on its health benefits business and continues to review its portfolio.
CVS Bolsters Primary Care With Completion Of $10.6 Billion Oak Street Health Deal
CVS Health completed its acquistion of Oak Street Health for $10.6 billion in cash, adding a large network of doctor-staffed clinics primarily used by seniors.
Humana Bounces Back, Sees Growth Of ‘At Least’ 775,000 Medicare Advantage Members
Humana, which made big investments in its Medicare business, now says its individual enrollment in Advantage plans would jump by “at least 775,000” for 2023.
Centene Profits Eclipse $1 Billion On Obamacare And Medicaid Growth
Centene reported more than $1.1 billion in first quarter profits thanks to a big boost in Obamacare enrollment.
Abbott Is Bouncing Back From Baby Formula Problems And Lost Covid Test Sales
Abbott Laboratories is rebounding from last year’s manufacturing shutdown of its U.S. baby formula plant thanks to strong medical device sales taking the place of lost revenue of COVID-19 tests.
